Manuel Baca,Stacey Drabic,Peter Emtage,Ronald Herbst
申请号:
US15593869
公开号:
US20170327588A1
申请日:
2017.05.12
申请国别(地区):
US
年份:
2017
代理人:
摘要:
Provided herein is a CD40L-Fc fusion protein and methods of using the fusion protein in the treatment of cancer comprising administering the CD40L-Fc fusion protein or the CD40L-Fc fusion protein in combination with one or more immune checkpoint inhibitors (e.g., an anti-CTLA4 antibody, anti-PD-L1 antibody).